Optimizing therapy of seizures in neurosurgery

Neurology

Volumn 67, Issue 12 SUPPL. 4, 2006, Pages

  Michelucci, Roberto ^a  

^a BELLARIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAMPTOTHECIN; CARBAMAZEPINE; CARMUSTINE; CHLORMETHINE; CISPLATIN; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETIRACETAM; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; LOMUSTINE; METHOTREXATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITROSOUREA; PHENOBARBITAL; PHENYTOIN; TAMOXIFEN; TAXANE DERIVATIVE; TEMOZOLOMIDE; TENIPOSIDE; VALPROIC ACID; VINBLASTINE; VINCA ALKALOID;

BRAIN CANCER; CANCER; CLINICAL TRIAL; EPILEPTOGENESIS; ERYTHEMA MULTIFORME; HEAD INJURY; HUMAN; NEUROSURGERY; NEUTROPENIA; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SEIZURE; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS;

EID: 33845711837     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.67.12_suppl_4.s14     Document Type: Review

References (40)

1. Jennett B. Epilepsy after non-missile head injuries. 2nd ed. Chicago: Year Book Medical, 1975.
2. Salazar AM, Jabbari B, Vance SC, Grafman J, Amin D, Dillon JD. Epilepsy after penetrating head injury. I, Clinical correlates: a report of the Vietnam Head Injury Study. Neurology 1985;35:1406-1414.
3. Wohns R, Wyler JK. Prophylactic phenytoin in severe head injuries. J Neurosurg 1979;51:507-509.
4. Servit Z, Musil F. Prophylactic treatment of posttraumatic epilepsy: results of a long-term follow-up in Czechoslovakia. Epilepsia 1981;22:315-320.
5. Rapport RL, Penry JK. A survey of attitudes toward the pharmacological prophylaxis of posttraumatic epilepsy. J Neurosurg 1973;38:159-166.
6. Young B, Rapp RP, Norton JA, Haack D, Tibbs PA, Bean JR. Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J Neurosurg 1983;58:236-241.
7. McQueen JK, Blackwood DHR, Harris P, Kalbag RM, Johnson AL. Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis. J Neurol Neurosurg Psychiatry 1983;46:899-904.
8. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497-502.
9. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of post-traumatic seizures: a randomised trial. J Neurosurg 1999;91:593-600.
10. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001;42:515-524.
11. Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003;60:10-16.
12. Glantz MJ, Cole BF, Friedberg MH, et al. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996;46:985-991.
13. Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54:1886-1893.
14. Packer RJ, Gurney JG, Punyko JA, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 2003;21:3255-3261.
15. Silver JM, Shin C, McNamara JO. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann Neurol 1991;29:356-363.
16. Pitkänen A. Prevention of epileptogenesis. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic drugs 5th ed. Philadelphia: Lippincott, Williams & Wilkins, 2002:169-176.
17. Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucbL059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 1998;284:474-479.
18. Amano K, Hamada K, Yagi K, Seino M. Antiepileptic effects of topiramate on amygdaloid kindling in rats. Epilepsy Res 1998;31:123-128.
19. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study on severe cutaneous adverse reactions. Lancet 1999;354:1033-1034.
20. Micali G, Linthicum K, Han N, West DP. Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies. Pharmacotherapy 1999;19:223-227.
21. Ahmed I, Reichenberg J, Lucas A, Shehan JM. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol 2004;43:67-73.
22. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285-2290.
23. Vecht CJ, Wagner GL, Wilms EB. Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2003;2:404-409.
24. Vecht CJ, Wagner GL, Wilms EB. Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents. Semin Oncol 2003;30(suppl 19):49-52.
25. Fetell MR, Grossman SA, Fisher JD, et al. Pre-irradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New approaches to brain tumor therapy central nervous system consortium. J Clin Oncol 1997;15:3121-3128.
26. Chang SM, Kuhn JG, Rizzo J, et al. Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium project. J Clin Oncol 1998;12:2188-2194.
27. Relling MV, Pui CH, Sandlund JT, et al. Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 2000;356:285-290.
28. Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W. P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 2005;723:255-260.
29. Bourg V, Lebrun C, Chichmanian RM, Thomas P, Frenay M. Nitrosourea-cisplatin-based chemotherapy associated with valproate: increase of hematologic toxicity. Ann Oncol 2001;12:217-219.
30. Grossman SA, Sheidler VR, Gilbert MR. Decreased phenytoin levels in patients receiving chemotherapy. Am J Med 1989;87:505-510.
31. Neef C, de Voogd-van der Straaten I. An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther 1988;43:372-375.
32. Gilbar PJ, Brodribb TR. Phenytoin and fluorouracil interaction. Ann Pharmacother 2001;35:1367-1370.
33. Rabinowicz AL, Hinton DR, Dyck P, Couldwell WT. High-dose tamoxifen in treatment of brain tumors: interaction with antiepileptic drugs. Epilepsia 1995;36:513-515.
34. Lackner TE. Interaction of dexamethasone with phenytoin. Pharmacotherapy 1991;11:344-347.
35. Van Breemen MS, Vecht CJ. Optimal seizure management in brain tumor patients. Curr Neurol Neurosci Rep 2005;5:207-213.
36. Khan RB, Hunt DL, Thompson SJ. Gabapentin to control seizures in children undergoing cancer treatment. J Child Neurol 2004;19:97-101.
37. Perry JR, Sawka C. Add-on gabapentin for refractory seizures in patients with brain tumors. Can J Neurol Sci 1996;23:128-131.
38. Penovich PE, Dickens DL, Gates JR, Moriarty GL, Gregory R, Dunn MB. Treating seizures due to brain neoplasms: rational new choices. Epilepsia 2004;45(suppl 7):311. Abstract.
39. Wagner GL, Wilms EB, van Donselaar CA, Vecht ChJ. Levetiracetam: preliminary experience in patients with primary brain tumors. Seizure 2003;12:585-586.
40. Striano S, Striano P, Boccella P, Nocerino C, Bilo L. Tiagabine in glial tumors. Epilepsy Res 2002;49:81-85.